The Effect of Empagliflozin on Kidney Injury Markers in Subjects with Type 2 Diabetes and Cardiovascular Disease: A Sub-analysis of the EMPA-HEART CardioLink-6 Trial
2019
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
86
References
0
Citations
NaN
KQI